Overview

• On June 30 Karnataka’s health commissioner formally wrote to the Drug Controller General of India to investigate alleged ethical lapses at Health Care Global Enterprises.
• Justice P Krishna Bhat stepped down as HCG’s ethics committee chair after raising whistleblower allegations about trial conduct.
• The state letter highlights patient safety risks, unchecked conflicts of interest, regulatory non-compliance and improper enrollment practices.
• The move reflects growing state intervention to uphold DCGI, Department of Health Research, ICMR and WHO standards in private-sector research.
• The DCGI’s response is pending and HCG has not issued any statement on the allegations.